Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

834.04
+7.400.90%
Post-market: 834.040.00000.00%19:58 EDT
Volume:786.92K
Turnover:656.91M
Market Cap:85.87B
PE:20.63
High:847.00
Open:835.74
Low:826.64
Close:826.64
52wk High:847.00
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:1.27
T/O Rate:0.80%
Dividend:3.64
Dividend Rate:0.44%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.71
PE(LYR):20.11

Loading ...

Sanofi Expects Moderate Increases in R&D Spend

Reuters
·
Jul 30

Regeneron Publishes Corporate Presentation Highlighting Q2 Pipeline Progress and Product Sales Trends

Reuters
·
Jul 30

Regeneron Beats Quarterly Estimates on Eczema Drug Strength, Shares Rise

Reuters
·
Jul 30

U.S. Stocks on the MOVE-Fortinet, Regeneron, Cigna

Reuters
·
Jul 30

Sanofi CEO, on Regeneron Partnership, Says Co's Main Objective Has Been to Rebuild Trust

THOMSON REUTERS
·
Jul 30

Drug Maker Regeneron Gains After Upbeat Q2 Results

Reuters
·
Jul 30

Regeneron Posts Higher 2Q Revenue, Sees Improving Profit

Dow Jones
·
Jul 30

Stock Track | Regeneron Pharmaceuticals Soars 5.69% in Pre-market as Q2 Earnings Blow Past Estimates

Stock Track
·
Jul 30

Regeneron Pharmaceuticals Q2 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
Jul 30

Regeneron Q2 Revenue Beats on Higher Dupixent, Eylea HD Sales

Reuters
·
Jul 30

Regeneron Q2 Adjusted EPS USD 14.29 Vs. IBES Estimate USD 10.3

Reuters
·
Jul 30

Regeneron Q2 FY26 GAAP EPS Falls 5% to $12.23; Revenue Rises 17% to $4.3 Billion

Reuters
·
Jul 30

Movement Alert|Regeneron Pharmaceuticals Rises 4.25% in Pre-Market Trading, Q2 Earnings Significantly Beat Expectations

Market Focus
·
Jul 30

Regeneron Pharmaceuticals Q2 Adj. EPS $14.29 Beats $10.26 Estimate, Sales $4.291B Beat $3.816B Estimate

Benzinga Earnings
·
Jul 30

Regeneron Pharmaceuticals - Q2 Eylea Hd U.S. Net Sales up 52% to $596 Mln

THOMSON REUTERS
·
Jul 30

Regeneron Q2 Adjusted EPS USD 14.29 VS. Ibes Estimate USD 10.3

THOMSON REUTERS
·
Jul 30

Regeneron Outlook FY Capex USD 1,030-1,100 Million

THOMSON REUTERS
·
Jul 30

Regeneron Pharmaceuticals - Q2 Dupixent Global Net Sales Rise 38% to $6 Bln

THOMSON REUTERS
·
Jul 30

Sanofi Drug Pipeline Worries, Dupixent Dependence Shake Shares

Reuters
·
Jul 30

Regeneron Pharmaceuticals Lawsuit Alleges Investors Were Misled Before REGN Stock Drops

TIPRANKS
·
Jul 29